Among other things, the experts say access is needed to staff and data from labs both in China and elsewhere that work with coronaviruses, including SARS-CoV-2, to assess biosafety and biosecurity practices.

US intelligence has ruled out that the coronavirus was developed as a weapon, and most agencies assess with 'low confidence' it was not genetically engineered.